| Lean | OB-NGT | IGT | AAb− T2D | AAb+ T2D | P value* |
---|---|---|---|---|---|---|
Total (% male) | 32 (56) | 31 (35) | 31 (35) | 34 (47) | 22 (45) | Â |
Age, years | 13 ± 0.2 | 14 ± 0.3 | 15 ± 0.4 | 15 ± 0.3 | 14 ± 0.5 | < 0.001 |
BMI, Z score (ZS) | -0.14 ± 0.15 | 2.21 ± 0.10 | 2.33 ± 0.06 | 2.39 ± 0.05 | 1.90 ± 0.12 | < 0.001 |
HbA1c (%) | 5.3 ± 0.1 | 5.4 ± 0.1 | 5.4 ± 0.1 | 6.6 ± 0.1 | 6.3 ± 0.2 | < 0.001 |
Fasting glucose, mg/dL | 95.3 ± 3.5 | 90.8 ± 3.5 | 92.5 ± 3.5 | 115.1 ± 3.4 | 129.1 ± 5.0 | < 0.001 |
2-h OGTT glucose, mg/dL | N/A | 111.4 ± 10.5 | 158.8 ± 8.4 | 197.5 ± 8.1 | 299.1 ± 12.1 | < 0.001 |
Treatment modality N (%) | ||||||
 Lifestyle |  |  |  | 7 (21) | 2 (13) |  |
 Insulin |  |  |  | 4 (12) | 3 (19) |  |
 Metformin |  |  |  | 16 (47) | 2 (13) |  |
 Insulin and metformin |  |  |  | 7 (21) | 9 (56) |  |